Psykey, Inc. (CEOS)
USD 0.01
(-9.68%)
USD 0.01
(-9.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.29 Million USD | -123.53% |
| 2022 | -355.79 Thousand USD | -7.28% |
| 2021 | -331.66 Thousand USD | 0.0% |
| 2020 | - USD | 100.0% |
| 2019 | -4329.00 USD | -501.39% |
| 2018 | -660.00 USD | 0.0% |
| 2016 | -570 Thousand USD | 54.98% |
| 2015 | -1.59 Million USD | -39.6% |
| 2014 | -1.24 Million USD | 0.0% |
| 2007 | -8.51 Million USD | 24.68% |
| 2006 | -10.59 Million USD | -41622.05% |
| 2005 | -25.77 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | -252.79 Thousand USD | 2.74% |
| 2023 FY | - USD | -123.53% |
| 2023 Q3 | -259.9 Thousand USD | -51.01% |
| 2023 Q1 | -110.51 Thousand USD | 0.7% |
| 2023 Q2 | -172.11 Thousand USD | -55.74% |
| 2022 FY | - USD | -7.28% |
| 2022 Q3 | -80.58 Thousand USD | 2.93% |
| 2022 Q4 | -111.29 Thousand USD | -38.11% |
| 2022 Q1 | -80.92 Thousand USD | 70.81% |
| 2022 Q2 | -83.01 Thousand USD | -2.58% |
| 2021 Q4 | -277.23 Thousand USD | -905.55% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | -12.1 Thousand USD | 0.0% |
| 2021 Q2 | -14.76 Thousand USD | -21.98% |
| 2021 Q3 | -27.57 Thousand USD | -86.79% |
| 2020 FY | - USD | 100.0% |
| 2019 FY | - USD | -501.39% |
| 2018 FY | - USD | 0.0% |
| 2016 FY | - USD | 54.98% |
| 2015 FY | - USD | -39.6% |
| 2014 FY | - USD | 0.0% |
| 2008 Q2 | -402.08 Thousand USD | 43.35% |
| 2008 Q3 | -2.24 Million USD | -457.95% |
| 2008 Q1 | -709.8 Thousand USD | -103.99% |
| 2007 Q2 | 2.96 Million USD | 225.34% |
| 2007 Q3 | -2.58 Million USD | -187.31% |
| 2007 Q1 | -2.36 Million USD | 31.3% |
| 2007 Q4 | -347.96 Thousand USD | 86.54% |
| 2007 FY | - USD | 24.68% |
| 2006 Q3 | -1.77 Million USD | 52.58% |
| 2006 FY | - USD | -41622.05% |
| 2006 Q4 | -3.43 Million USD | -94.0% |
| 2006 Q1 | -1.75 Million USD | 0.0% |
| 2006 Q2 | -3.73 Million USD | -113.48% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | -34.374% |
| Ansell Limited | 209.86 Million USD | 100.617% |
| Ansell Limited | 206.3 Million USD | 100.628% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 103.024% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 20.287% |
| ConvaTec Group Plc | 455.5 Million USD | 100.284% |
| ConvaTec Group Plc | 455.5 Million USD | 100.284% |
| Encision Inc. | -544.19 Thousand USD | -138.022% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -813.408% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -1078.299% |
| Innovative MedTech Inc. | -7.67 Million USD | 83.12% |
| LifePoint, Inc. | -14.2 Million USD | 90.88% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 79.064% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -298.555% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -501.812% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -219.21% |
| SmileDirectClub, Inc. | -186.13 Million USD | 99.304% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.289% |
| SheerVision, Inc. | -110.53 Thousand USD | -1071.892% |
| United Health Products, Inc. | -2.5 Million USD | 48.234% |
| Vasamed, Inc. | -4.57 Million USD | 71.684% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 42.704% |
| Yubo International Biotech Limited | -1.17 Million USD | -9.987% |